The 50-day moving average for GERN moved below the 200-day moving average on September 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GERN as a result. In 91 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The 10-day moving average for GERN crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GERN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for GERN entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GERN's RSI Indicator exited the oversold zone, 25 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for GERN just turned positive on October 08, 2026. Looking at past instances where GERN's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.
Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where GERN advanced for three days, in 170 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
GERN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. GERN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.674) is normal, around the industry mean (26.782). GERN has a moderately high P/E Ratio (220.000) as compared to the industry average of (43.395). Projected Growth (PEG Ratio) (16.670) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (4.250) is also within normal values, averaging (437.542).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GERN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TVTX moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TVTX as a result. In 82 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The 10-day moving average for TVTX crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TVTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for TVTX entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for TVTX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where TVTX advanced for three days, in 221 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
TVTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. TVTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TVTX's P/B Ratio (238.095) is slightly higher than the industry average of (26.782). P/E Ratio (17.370) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (5.690) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (9.794) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GERN | TVTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 44 | |
SMR RATING 1..100 | 97 | 99 | |
PRICE GROWTH RATING 1..100 | 72 | 42 | |
P/E GROWTH RATING 1..100 | 60 | 32 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TVTX's Valuation (96) in the Biotechnology industry is in the same range as GERN (100). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.
TVTX's Profit vs Risk Rating (44) in the Biotechnology industry is somewhat better than the same rating for GERN (100). This means that TVTX’s stock grew somewhat faster than GERN’s over the last 12 months.
GERN's SMR Rating (97) in the Biotechnology industry is in the same range as TVTX (99). This means that GERN’s stock grew similarly to TVTX’s over the last 12 months.
TVTX's Price Growth Rating (42) in the Biotechnology industry is in the same range as GERN (72). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.
TVTX's P/E Growth Rating (32) in the Biotechnology industry is in the same range as GERN (60). This means that TVTX’s stock grew similarly to GERN’s over the last 12 months.
| GERN | TVTX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 1 day ago 89% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 89% | 2 days ago 83% |
| MACD ODDS (%) | 1 day ago 83% | N/A |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 80% |
| Advances ODDS (%) | 8 days ago 77% | 12 days ago 78% |
| Declines ODDS (%) | 3 days ago 79% | 1 day ago 76% |
| BollingerBands ODDS (%) | 1 day ago 87% | 1 day ago 84% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 80% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GERN’s FA Score shows that 0 FA rating(s) are green while TVTX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GERN’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).
GERN (@Biotechnology) experienced а -4.49% price change this week, while TVTX (@Biotechnology) price change was -4.84% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
GERN is expected to report earnings on Nov 11, 2026.
TVTX is expected to report earnings on Oct 22, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QBQF | 25.98 | N/A | N/A |
| AllianzIM Growth-100 Buffer15 ETF (QBQF) | |||
| LDP | 18.95 | -0.03 | -0.16% |
| Cohen & Steers Limited | |||
| KAPR | 38.90 | -0.36 | -0.92% |
| Innovator U.S. Small Cap Power Buffer ETF - April (KAPR) | |||
| CGXU | 32.58 | -0.54 | -1.63% |
| Capital Group International Focus Equity ETF (CGXU) | |||
| ACSG | 44.20 | -1.10 | -2.42% |
| American Century Small Cap Growth Insights ETF (ACSG) | |||
A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.
| Ticker / NAME | Correlation To GERN | 1D Price Change % | ||
|---|---|---|---|---|
| GERN | 100% | -4.88% | ||
| SER - GERN | 66% Loosely correlated | -3.91% | ||
| VCYT - GERN | 44% Loosely correlated | -2.86% | ||
| SLDB - GERN | 41% Loosely correlated | -3.66% | ||
| TVTX - GERN | 40% Loosely correlated | -6.04% | ||
| VIR - GERN | 40% Loosely correlated | -4.87% | ||
More | ||||
A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with MGTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To TVTX | 1D Price Change % | ||
|---|---|---|---|---|
| TVTX | 100% | -6.04% | ||
| MGTX - TVTX | 47% Loosely correlated | -6.17% | ||
| GERN - TVTX | 42% Loosely correlated | -4.88% | ||
| LGND - TVTX | 41% Loosely correlated | -0.99% | ||
| VCYT - TVTX | 37% Loosely correlated | -2.86% | ||
| LXEO - TVTX | 37% Loosely correlated | -4.35% | ||
More | ||||